Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis.

Ouédraogo, D-D; Palazzo, E; Nicaise-Roland, P; Somogyi, N; Grootenboer-Mignot, S; Hayem, G; Meyer, O

Ouédraogo, D-D; Palazzo, E; Nicaise-Roland, P; Somogyi, N; Grootenboer-Mignot, S; Hayem, G; Meyer, O.

Clin Exp Rheumatol ; 25(6): 930-1, 2007.

Article in En | MEDLINE | ID: mdl-18173933

Subject(s)

Arthritis, Psoriatic/immunology; Autoantibodies/blood; Peptides, Cyclic/immunology; Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Retrospective Studies

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Autoantibodies / Arthritis, Psoriatic Type of study: Observational_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Rheumatol Year: 2007 Document type: Article

Search on Google

XML

PubMed Links